HALO

#1029
Halozyme Therapeutics, Inc.
67.4200 USD
+0.16%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
67.4000
67.7400
年范围
61.2250
82.2200
日变化
+0.16%
每月变动
+4.77%
6个月变化
+0.93%
年变化
+0.93%
前一天收盘价
67.3100
开盘价
67.4700
买价
卖价
最低价
67.4000
High
67.7400
交易量
72
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 7.9567 B
  • Employee 423
  • Founded 1998
  • CEO Helen I. Torley
  • Website www.halozyme.com
  • Headquarter Delaware, United States
  • FIGI BBG000CZ8W54
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
26.29
市销率
5.97

Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

新闻